|
[1]
|
Surks, M.I., Ortiz, E., Daniels, G.H., Sawin, C.T., Col, N.F., et al. (2004) Subclinical Thyroid Disease: Scientific Re-view and Guidelines for Diagnosis and Management. JAMA, 291, 228-238. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Consensus Development Conference: Diagnosis, Prophylaxis, and Treatment of Osteoporosis. The American Journal of Medicine, 94, 646-650.[CrossRef]
|
|
[3]
|
Biondi, B., Cappola, A.R. and Cooper, D.S. (2019) Subclini-cal Hypothyroidism: A Review. JAMA, 322, 153-160. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Peeters, R.P. (2017) Subclinical Hypothyroidism. New England Journal of Medicine, 377, 1404. [Google Scholar] [CrossRef]
|
|
[5]
|
Cooper, D.S. and Biondi, B. (2012) Subclinical Thyroid Disease. Lancet, 379, 1142-1154. [Google Scholar] [CrossRef]
|
|
[6]
|
Pearce, S.H.S., Brabant, G., Duntas, L.H., Monzani, F., Peeters, R.P., et al. (2013) 2013 ETA Guideline: Management of Subclinical Hypothyroidism. European Thyroid Jour-nal, 2, 215-228. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Evron, J.M. and Papaleontiou, M. (2021) Decision Mak-ing in Subclinical Thyroid Disease. Medical Clinics of North America, 105, 1033-1045. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Fatourechi, V. (2009) Subclinical Hypothyroidism: An Update for Primary Care Physicians. Mayo Clinic Proceedings, 84, 65-71. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Canaris, G.J., Manowitz, N.R., Mayor, G. and Ridgway, E.C. (2000) The Colorado Thyroid Disease Prevalence Study. Archives of In-ternal Medicine, 160, 526-534. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Nakajima, Y., Yamada, M., Aku-zawa, M., Ishii, S., Masamura, Y., et al. (2013) Subclinical Hypothyroidism and Indices for Metabolic Syndrome in Japanese Women: One-Year Follow-Up Study. Journal of Clinical Endocrinology & Metabolism, 98, 3280-3287. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Mitchell, A.L. and Pearce, S.H.S. (2010) How Should We Treat Patients with Low Serum Thyrotropin Concentrations? Clinical Endocrinology, 72, 292-296. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Tsai, K. and Leung, A.M. (2021) Subclinical Hyperthy-roidism: A Review of the Clinical Literature. Endocrine Practice, 27, 254-260. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Ross, D.S., Burch, H.B., Cooper, D.S., Greenlee, M.C., Laurberg, P., et al. (2016) 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid, 26, 1343-1421. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Hollowell, J.G., Staehling, N.W., Flanders, W.D., Hannon, W.H., Gunter, E.W., et al. (2002) Serum TSH, T4, and Thyroid Anti-bodies in the United States Population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). The Journal of Clinical Endocrinology & Metabolism, 87, 489-499. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Vadiveloo, T., Donnan, P.T., Cochrane, L. and Leese, G.P. (2011) The Thyroid Epidemiology, Audit, and Research Study (TEARS): The Natural History of Endogenous Subclinical Hyper-thyroidism. The Journal of Clinical Endocrinology & Metabolism, 96, E1-E8. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Vejbjerg, P., Knudsen, N., Perrild, H., Laurberg, P., Carlé, A., et al. (2009) Lower Prevalence of Mild Hyperthyroidism Related to a Higher Iodine Intake in the Population: Prospective Study of a Mandatory Iodization Programme. Clinical Endocrinology, 71, 440-445. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Mariotti, S., Barbesino, G., Caturegli, P., Bartalena, L., Sansoni, P., et al. (1993) Complex Alteration of Thyroid Function in Healthy Centenarians. The Journal of Clinical En-docrinology & Metabolism, 77, 1130-1134. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Aghini-Lombardi, F., Antonangeli, L., Martino, E., Vitti, P., Mac-cherini, D., et al. (1999) The Spectrum of Thyroid Disorders in an Iodine-Deficient Community: The Pescopagano Sur-vey. The Journal of Clinical Endocrinology & Metabolism, 84, 561-566. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Nicholls, J.J., Brassill, M.J., Williams, G.R. and Bassett, J.H. (2012) The Skeletal Consequences of Thyrotoxicosis. Journal of Endocrinology, 213, 209-221. [Google Scholar] [CrossRef]
|
|
[20]
|
Maioli, M., Contini, G., Santaniello, S., Bandiera, P., Pigliaru, G., Sanna, R., Rinaldi, S., Delitala, A.P., Montella, A., Bagella, L., et al. (2013) Amniotic Fluid Stem Cells Morph into a Cardiovascular Lineage: Analysis of a Chemically Induced Cardiac and Vascular Commitment. Drug Design, Develop-ment and Therapy, 7, 1063-1073. [Google Scholar] [CrossRef]
|
|
[21]
|
Vortkamp, A., Lee, K., Lanske, B., Segre, G.V., Kronenberg, H.M. and Tabin, C.J. (1996) Regulation of Rate of Cartilage Differentiation by Indian Hedgehog and PTH-Related Protein. Science, 273, 613-622. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Minina, E., Kreschel, C., Naski, M.C., Ornitz, D.M. and Vort-kamp, A. (2002) Interaction of FGF, Ihh/Pthlh, and BMP Signaling Integrates Chondrocyte Proliferation and Hyper-trophic Differentiation. Developmental Cell, 3, 439-449. [Google Scholar] [CrossRef]
|
|
[23]
|
St-Jacques, B., Hammerschmidt, M. and McMahon, A.P. (1999) Indian Hedgehog Signaling Regulates Proliferation and Differentiation of Chondrocytes and Is Essential for Bone Formation. Genes & Development, 13, 2072-2086. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
朱大年, 王庭槐. 生理学[M]. 第9版. 北京: 人民卫生出版社, 2018: 392.
|
|
[25]
|
Abe, E., Marians, R.C., Yu, W., Wu, X.B., Ando, T., Li, Y., Iqbal, J., Eldeiry, L., Rajendren, G., Blair, H.C., et al. (2003) TSH Is a Negative Regulator of Skeletal Remodeling. Cell, 115, 151-162. [Google Scholar] [CrossRef]
|
|
[26]
|
Hase, H., Ando, T., Eldeiry, L., Brebene, A., Peng, Y., Liu, L., Amano, H., Davies, T.F., Sun, L., Zaidi, M., et al. (2006) TNF α Mediates the Skeletal Effects of Thyroid-Stimulating Hormone. Proceedings of the National Academy of Sciences of the United States of America, 103, 12849-12854. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Baliram, R., Latif, R., Berkowitz, J., et al. (2011) Thy-roid-Stimulating Hormone Induces a Wnt-Dependent, Feed-Forward Loop for Osteoblastogenesis in Embryonic Stem Cell Cultures. Proceedings of the National Academy of Sciences of the United States of America, 108, 16277-16282. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Jonklaas, J., Bianco, A.C., Bauer, A.J., Burman, K.D., Cappola, A.R., et al. (2014) Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement. Thyroid, 24, 1670-1751. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Garber, J.R., Cobin, R.H., Gharib, H., Hennessey, J.V., Klein, I., et al. (2012) Clinical Practice Guidelines for Hypothyroidism in Adults: Cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocrine Practice, 18, 988-1028. [Google Scholar] [CrossRef]
|
|
[30]
|
Biondi, B., Bartalena, L., Cooper, D.S., Hegedus, L., Laurberg, P., et al. (2015) The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hy-perthyroidism. European Thyroid Journal, 4, 149-163. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Bahn, R.S., Burch, H.B., Cooper, D.S., Garber, J.R., Greenlee, M.C., et al. (2011) Hyperthyroidism and Other Causes of Thyrotoxicosis: Management Guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid, 21, 593-646. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Biondi, B. and Cooper, D.S. (2018) Subclinical Hyperthyroidism. New England Journal of Medicine, 378, 2411-2419. [Google Scholar] [CrossRef]
|
|
[33]
|
Grais, I.M. and Sowers, J.R. (2014) Thyroid and the Heart. The American Journal of Medicine, 127, 691-698. [Google Scholar] [CrossRef] [PubMed]
|